Lille, France

Catherine Michalski


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 1994-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Catherine Michalski: Innovator in Biopharmaceuticals

Introduction

Catherine Michalski is a prominent inventor based in Lille, France. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of high-purity factor IX concentrates. Her work has led to advancements that are crucial for patients requiring specific blood factor treatments.

Latest Patents

Catherine holds 3 patents, with her latest inventions focusing on the production of inter-alpha-trypsin inhibitor concentrates and high-purity human factor IX concentrates. The methods she developed involve sophisticated purification techniques, including DEAE-Sephadex chromatography and affinity chromatography on heparin-sepharose. These processes ensure that the resulting Factor IX fraction has a specific activity of at least 0.5 IU/mg protein, which is essential for therapeutic applications.

Career Highlights

Throughout her career, Catherine has worked with notable organizations such as the Association pour l'Essor de la Transfusion Sanguine dans la Région du Nord and the Centre Régional de Transfusion Sanguine de Lille. Her expertise in biopharmaceuticals has positioned her as a key figure in the development of life-saving treatments.

Collaborations

Catherine has collaborated with esteemed colleagues, including Dominique Dernis and Thierry Burnouf. These partnerships have fostered innovation and have been instrumental in advancing her research and development efforts.

Conclusion

Catherine Michalski's contributions to the field of biopharmaceuticals highlight her role as an innovator dedicated to improving patient care through advanced medical treatments. Her patents and collaborations reflect her commitment to excellence in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…